STAT+: U.K. researchers warn about biases in medical devices, health care algorithms
LONDON — Regulators, clinicians, and health care algorithm developers need to take additional steps to…
Category: Medicine
Preventing the weaponization of AI-designed proteins
Want to stay on top of the science and politics driving biotech today? Sign up to get…
.jpg)
STAT+: UnitedHealth is on a buying spree of outpatient surgery centers
UnitedHealth Group quietly acquired dozens of outpatient facilities in 2023, with a particular focus on…
Amid the battle over abortion rights, a failure to agree on how to define abortion
Every year, Lisa Campo-Engelstein tells her medical ethics class the story of Isabel: A fictional…
Opinion: Disabled scientists are often left out of academia. The NIH can help change that
Despite being the largest minority in the nation, disabled people like us have been structurally…
STAT+: Medicare announces loan program to aid providers affected by Change cyberattack
Medicare announced on Saturday that it will make advance payments available to physician groups, hospitals,…
Opinion: STAT readers on new CDC Covid guidelines, weight loss drugs and mental health, and new psychiatric meds
STAT now publishes selected Letters to the Editor received in response to First Opinion essays…
STAT+: Amylyx ALS drug failure leaves patients, advocates, and researchers reeling — and wondering what’s next
The latest disappointment in amyotrophic lateral sclerosis research brought crushing news for patients and physicians,…
STAT+: Obesity drug Wegovy gets FDA approval to add cardiovascular benefits on its label
U.S. regulators approved a label expansion for Novo Nordisk’s obesity drug Wegovy to tout its…
STAT+: UnitedHealth gives timeline for Change restoration: payments up by late next week
Change Healthcare’s parent company said it’ll have its electronic payment function up and running by…
Eli Lilly’s anti-vanity ad campaign for Oscars
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about Lilly Alzheimer’s drug adcomm, Amylyx ALS drug flop, and more
And so, another working week will soon draw to a close. Not a moment too…
STAT+: In surprise move, FDA calls for advisory committee on Lilly’s Alzheimer’s drug
In a surprise move, the Food and Drug Administration has called for a meeting of…
STAT+: In stunning outcome, Amylyx’s ALS drug fails large clinical trial
Amylyx Pharmaceuticals said Friday that its treatment for ALS, called Relyvrio, failed to provide any…
STAT+: IVF doctors demand full details on fluid that grows embryos amid CooperSurgical lawsuits
Patients from all over the country are filing lawsuits against medical supply giant CooperSurgical, alleging…
STAT+: Biden’s SOTU highlights pharma’s biggest political problem: It is terrifyingly, awfully alone
If you’re a drug company executive, you probably feel like you got up on the…
A disabled artist’s journey from ‘Oh, sorry’ to social justice activism
Sonya Rio-Glick was born three months and six days premature, alongside her twin, in the…
Opinion: STAT+: It’s time to rethink everything about our approach to psychiatric drug development
In many ways, psychiatry is still flying blind. People experiencing mental health conditions are prescribed…
Biden calls for election wake-up call on abortion rights — but new upheavals are fast approaching
WASHINGTON — President Biden started his sprawling national address Thursday night with a warning to…
In his State of the Union, Biden takes clear aim at ‘Big Pharma’
WASHINGTON — Often, a president’s State of the Union address is a staid affair, with…
STAT+: Pharma giants, government spar in court over Medicare drug price negotiation
TRENTON, N.J. — Pharma industry giants including Bristol Myers Squibb, Johnson and Johnson, Novartis, and…
Listen: VC turmoil, GLP-1 competition, & the war on recovery
Why are addiction treatments so hard to get? Can small companies compete in obesity? And…
RSV monoclonal Beyfortus was 90% effective at preventing hospitalizations in children this winter: CDC
A new monoclonal antibody product to protect against respiratory syncytial virus was 90% effective at…
STAT+: Pharmalittle: We’re reading about a Lilly obesity-drug ad, a $35 cap on inhalers, and more
Rise and shine, everyone, another busy day is on the way. Moreover, this is shaping…
Banning WuXi is more complicated than it might sound
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Former medical device CEO who sold dummy, plastic parts convicted of fraud
A New York jury on Wednesday convicted the former CEO of Stimwave, a company that…
STAT+: Novo Nordisk’s obesity pill bests Wegovy in early trial
A pill being developed by Danish drugmaker Novo Nordisk may lead to greater weight loss…
STAT+: Boehringer Ingelheim to cap asthma inhaler out-of-pocket costs at $35
Facing criticism over its pricing, Boehringer Ingelheim plans to cap out-of-pocket costs at $35 a…
STAT+: Nursing home owners can hide nearly two-thirds of their profits, new study shows
A new study shows that some nursing homes are shunting the majority of their profits…
Opinion: Free tuition won’t fix medicine’s diversity problem without admissions reform
Medical students at Albert Einstein School of Medicine in New York City gathered last week…
Girls are starting puberty earlier than ever. For some, that comes with major mental health risks
Zaria was just 9 years old when a nurse practitioner delivered news that rocked her…
STAT+: A deep dive into Applied Therapeutics’ data, and questions on Cassava’s erased data
Have you heard the news? I’m launching a weekly email newsletter starting on March 28….
Microplastics found in blood vessels linked to greater risk of heart problems, study finds
Micro and nanoplastics, tiny pieces of plastic scattered throughout the environment, have been increasingly found…
Biden to propose expanding Medicare drug price negotiation in State of the Union
WASHINGTON — President Biden wants to more than double the size of Medicare’s new drug…
STAT+: Senate panel advances bill to ban some Chinese biotechs, with Sen. Paul taking up industry’s cause
WASHINGTON — A Senate panel today passed a bill aimed at preventing certain Chinese companies…
Opinion: The CDC’s new, relaxed Covid isolation guidance makes perfect sense
What makes for good public health guidance? That’s the conversation I was having with a…
Bayer’s not breaking up. At least not yet
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Pharmalittle: We’re reading about HIV drug resistance, march-in rights, and more
Good morning, everyone, and how are you today? We are doing just fine, thank you….
Startup Alumis raises $259 million as it prepares for psoriasis trial
San Francisco startup Alumis Inc. has raised $259 million in a bid to best big…
STAT+: With Meta’s backing, Headspace launches into VR
Headspace, which has built a growing digital health business around mindfulness, is joining forces with…
Florida health officials provide scant details on measles cases, worrying health experts
On Sunday, public health officials in two Michigan counties warned their residents that they may…
STAT+: Republicans consider a new attack on Biden ‘march-in’ plan for lower drug prices
WASHINGTON — Republicans in Congress might try to use a technical maneuver to block the…
STAT+: Oracle Health chair says Cerner isn’t competing with Epic
Cerner may have ceded U.S. business to reigning electronic health records market leader Epic Systems,…
Opinion: Charging patients to message their doctors mostly benefits major hospital systems
Thinking about messaging your physician about a weird rash? You may want to hold off…
Air quality improvements belie rising racial and ethnic disparities in pollutant-related deaths, study finds
The U.S. is making progress in reducing the public health consequences of air pollutants and…
STAT+: FDA clears first over-the-counter continuous glucose monitor
For the first time, anyone in the United States will soon be able to buy…
STAT+: Large insurers say up to one-quarter of claims run through Change Healthcare
Some of the country’s biggest health insurers said Tuesday that up to one-quarter of their…
FDA advisory panel recommends a streamlined flu vaccine for next fall
When Americans line up for flu vaccines next fall, they will almost certainly be getting…
STAT+: Harvard longevity scientist sparks furor with claim about reversing aging in dogs
Renowned Harvard University geneticist and longevity researcher David Sinclair recently made an astonishing assertion: Scientists…
It’s time to stop treating menopause like a disease, researchers argue in series of Lancet articles
One in eight people is postmenopausal, and about 50 million women enter menopause every year….